- Home
- GRI vs DATS Comparison
GRI vs DATS Comparison
Compare GRI & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRI
- DATS
- Stock Information
- Founded
- GRI 2018
- DATS 2014
- Country
- GRI United States
- DATS United States
- Employees
- GRI N/A
- DATS N/A
- Industry
- GRI Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- GRI Health Care
- DATS Technology
- Exchange
- GRI Nasdaq
- DATS Nasdaq
- Market Cap
- GRI 6.1M
- DATS 5.2M
- IPO Year
- GRI N/A
- DATS 2021
- Fundamental
- Price
- GRI $0.72
- DATS $5.23
- Analyst Decision
- GRI Strong Buy
- DATS
- Analyst Count
- GRI 2
- DATS 0
- Target Price
- GRI $11.50
- DATS N/A
- AVG Volume (30 Days)
- GRI 182.9K
- DATS 24.6M
- Earning Date
- GRI 11-14-2024
- DATS 11-14-2024
- Dividend Yield
- GRI N/A
- DATS N/A
- EPS Growth
- GRI N/A
- DATS N/A
- EPS
- GRI N/A
- DATS N/A
- Revenue
- GRI N/A
- DATS $515.00
- Revenue This Year
- GRI N/A
- DATS N/A
- Revenue Next Year
- GRI N/A
- DATS N/A
- P/E Ratio
- GRI N/A
- DATS N/A
- Revenue Growth
- GRI N/A
- DATS N/A
- 52 Week Low
- GRI $0.30
- DATS $1.01
- 52 Week High
- GRI $65.00
- DATS $9.34
- Technical
- Relative Strength Index (RSI)
- GRI 44.58
- DATS 57.65
- Support Level
- GRI $0.68
- DATS $4.09
- Resistance Level
- GRI $0.77
- DATS $7.18
- Average True Range (ATR)
- GRI 0.07
- DATS 1.48
- MACD
- GRI -0.01
- DATS 0.24
- Stochastic Oscillator
- GRI 16.44
- DATS 45.99
About GRI GRI Bio Inc.
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist, for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.